Press Releases

 
Press Releases
  Date Title View
Aug 31, 2015
ALBANY, N.Y., Aug. 31, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived active pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca's strength in extracting opiates from plant bi...
Aug 4, 2015
ALBANY, N.Y., Aug. 4, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2015. Highlights: Second quarter contract revenue of $85.2 million, a 39% increase from 2014 Adjusted contract margins of 26% Second quarter adjusted diluted EPS of $0.22, incl...
Jul 21, 2015
ALBANY, N.Y., July 21, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2015 financial results before the opening of the market on Tuesday, August 4, 2015. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can ...
Jul 16, 2015
ALBANY, N.Y., July 16, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product. The purchase price was $174 mill...
Jun 17, 2015
BUFFALO, N.Y., June 17, 2015 /PRNewswire/ -- As further evidence of Governor Andrew M. Cuomo's successful establishment of a dynamic and growing bio-pharma sector in Buffalo, New York, Albany Molecular Research Inc. (NASDAQ: AMRI) and PerkinElmer, Inc. today announced the formation of a strategic collaboration in connection with the opening of AMRI...
Jun 1, 2015
BUFFALO, N.Y., June 1, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. As part of the three-year agreement, AMRI gains...
May 20, 2015
ALBANY, N.Y., May 20, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at Jefferies 2015 Healthcare Conference on Monday, June 1, 2015 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor...
May 5, 2015
ALBANY, N.Y., May 5, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2015. Highlights: First quarter contract revenue of $75.1 million, up 47% from 2014 First quarter royalties of $6.7 million, down 19% from 2014 First quarter adjusted diluted EP...
May 1, 2015
ALBANY, N.Y., May 1, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015 at 4:20 p.m. ET. A live audio webcast of the presentation can be ...
Apr 21, 2015
ALBANY, N.Y., April 21, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2015 financial results before the opening of the market on Tuesday, May 5, 2015.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can be...
Page:
1
... NextLast
= add release to Briefcase